Merck

Merck continues plans to cut jobs

Friday, July 15, 2011 10:07 AM

Last year, Merck disclosed plans to save up to $3.5 billion by closing numerous research sites and manufacturing plants and eliminate roughly 15,000 jobs by 2012, or roughly 10% of the total headcount including the thousands of employees who were part of the 2009 acquisition of Schering-Plough. Before that deal, Merck employed about 53,000 people, reported Pharmalot.

More... »

Gilead to allow generic AIDS drugs through Medicines Patent Pool

Wednesday, July 13, 2011 10:46 AM

Gilead Sciences will allow some of its AIDS drugs to be made by generic manufacturers, potentially increasing their availability in poor countries, particularly in Africa, according to the Associated Press.

More... »

Lilly pitches plan to overcome key patent losses

Friday, July 8, 2011 10:15 AM

Eli Lilly, only months away from losing patent protection for its top-selling drug, told investors the keys to overcoming this and other patent losses lie in its labs and emerging markets including China, according to Mercury News.

More... »

Merck Serono changes R&D organizational structure

Thursday, July 7, 2011 02:02 PM

Merck Serono, a division of Merck of Darmstadt, Germany, is putting a new organizational structure for research and development into effect. Two dedicated groups, focusing on different stages of pharmaceutical innovation (pre- and post- proof-of-concept), will be created as a first step in redesigning Merck Serono's R&D model.

More... »

Merck strategically shedding compounds

Thursday, July 7, 2011 10:05 AM

Almost as soon as the Merck and Schering-Plough pipelines were combined in late 2009, Merck had to go through all of its compounds and decide which to shed, according to Chemical & Engineering News.

More... »

MS research funding awards given

Wednesday, July 6, 2011 10:13 AM

Merck Serono and Fast Forward announced the second group of recipients to receive funding designed to speed research advances in high potential areas of multiple sclerosis (MS) research.

More... »

Merck commits to sharing study protocols

Tuesday, July 5, 2011 12:24 PM

Merck will voluntarily include the research protocol and statistical analysis plan among the materials it supplies to medical journals when it submits clinical study manuscripts for publication, according to a PharmaTimes report.

More... »

Merck signs HCV agreement with Roche

Wednesday, May 18, 2011 12:05 PM

Merck and Roche have signed a pact to sell Merck’s recently approved hepatitis C drug Victrelis and explore combination treatments for the disease.

More... »

Merck plans to close Inspire headquarters and cut jobs

Tuesday, May 17, 2011 12:31 PM

With Merck’s purchase of Inspire Pharmaceuticals comes jobs cuts, relocation, and the closing of  Inspire headquarters in North Carolina. It's unclear how many jobs will be cut, but senior Inspire executives are preparing to leave, the News & Observer reports.

More... »

Merck’s Victrelis approved by FDA

Monday, May 16, 2011 12:50 PM

Merck’s new hepatitis C drug Victrelis has received FDA approval according to Pharma Times. The approval is based on two phase III trials with 1,500 adults.

More... »